Slotnik Capital, LLC Inhibrx, Inc. Transaction History

Slotnik Capital, LLC

  • $206 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$32.76 - $39.56 $13.8 Million - $16.6 Million
419,778 New
419,778 $14.7 Billion

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $626M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Slotnik Capital, LLC Portfolio

Follow Slotnik Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slotnik Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slotnik Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email